Study CAMBIMED: Effects of changes in medication appearance on safety of antihypertensive and hypolipidemic treatments in chronic patients older than 65 years in primary health care
DiscussionFor drugs of the same active ingredient, the effect that different package appearances and presentation may have on the safety of patients undergoing chronic treatments is unknown under the new legislative framework. There are various initiatives that promote the iso-appearance of drugs: “If they are the same, make them look the same”. It is to be expected that older, multi-medicated patients with chronic pathologies will be the ones under a greater risk of suffering from this problem.
Source: BMC Public Health - Category: Consumer Health News Authors: Jesús Arancon-MongeAlicia de-Castro-CuencaÁngel Serrano-VázquezLuz Campos-DíazMontserrat Díaz-ErasoIsabel del Cura-GonzálezElena Polentinos-CastroRicardo Rodríguez-BarrientosAutores Colaboradores: GRUPO CAMBIMED Source Type: research
More News: Enalapril | Health | Health Management | International Medicine & Public Health | Norvasc | Simvastatin | Statin Therapy | Study | Zocor